Similar articles

• Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?

  ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH. ElBardissi AW, et al. J Thorac Cardiovasc Surg. 2010 May;139(5):1137-45. doi: 10.1016/j.jtcvs.2009.10.064. Epub 2010 Mar 19. J Thorac Cardiovasc Surg. 2010. PMID: 20303508
• Is early antithrombotic therapy necessary after tissue mitral valve replacement?

  Colli A, D'Amico R, Mestres CA, Pomar JL, Cámara ML, Ruyra X, Mulet J. Colli A, et al. J Heart Valve Dis. 2010 Jul;19(4):405-11. J Heart Valve Dis. 2010. PMID: 20845885
• Anticoagulation after bioprosthetic aortic valve replacement.

  Nowell J, Jahangiri M. Nowell J, et al. J Thorac Cardiovasc Surg. 2010 Nov;140(5):1201-2; author reply 1202. doi: 10.1016/j.jtcvs.2010.06.058. J Thorac Cardiovasc Surg. 2010. PMID: 20951265 No abstract available.
• Managing mechanical valves with reduced anticoagulation.

  Slaughter MS, Jweied E. Slaughter MS, et al. Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1073-85. doi: 10.1586/14779072.5.6.1073. Expert Rev Cardiovasc Ther. 2007. PMID: 18035923 Review.
• Optimal Anticoagulation After Tissue Aortic and Mitral Valve Replacement.

  Moonsamy P, Mohan N, Melnitchouk S. Moonsamy P, et al. Semin Thorac Cardiovasc Surg. 2020 Summer;32(2):197-201. doi: 10.1053/j.semtcvs.2019.11.010. Epub 2019 Dec 20. Semin Thorac Cardiovasc Surg. 2020. PMID: 31870926 Review. No abstract available.